Health Care
As pandemic boom fades, Moderna’s market momentum reverses
Moderna, which led the biotechnology sector’s pandemic-driven surge, struggles to keep pace with the market.
Section
Health Care
Company Insights
Eli Lilly races to fend off competitors in weight-loss drug market
Eli Lilly bulks up on supply and lawsuits to ward off competition in the booming weight loss market
COVID-19
Small biotech poised for a cure after years of plunging stock
Small-cap biotech stocks plundered after a 2021 wild-run, but investors are hopeful that interest rate cuts and positive test results in oncology and autoimmune treatments will be the right prescription for the biopharma market.
Health Care
Aging America Nudging UnitedHealth to Invest in Home Care
UnitedHealth Group is snapping up home-based care operators on a bet that as more Americans get older and sicker, they will want health services under their own roof.
Earnings
UnitedHealth’s Earnings Driven by Lower Medical Cost as Company Raises Guidance
UnitedHealth’s third-quarter earnings were driven by the strong top and bottom lines, quelling investors’ concerns about increasing medical services and costs among seniors.
Cigna
Immune to market slump, these four major healthcare stocks are on an expansion kick
The economy may be ailing but dominant healthcare stocks have so far resisted infection, and look poised to continue thriving.